
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Designed for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, Mitotane is distinguished by its precise regulation and inhibition of adrenal c···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:212
Mitotane was developed to address inoperable adrenal cortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, and its core mechanism is the careful regulation and inhib···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:224
Mitotaneis specific for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced cortisol hyperactivity, and its essence lies in the precise inhibition of adrenal cort···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:252
Mitotane is specifically developed for the treatment of inoperable adrenal cortical carcinoma, hyperplasia, and neoplastic hypercortisolism, and its core mechanism of action is to ···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:228
Mitotane is specifically designed for the treatment of inoperable adrenal carcinoma, hyperplasia, and tumor-induced cortisol excess, and its core efficacy lies in the suppression o···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:251
Mitotane is a drug dedicated to the treatment of adrenocortical carcinoma (inoperable), hyperplasia, and tumor-induced hypercortisolism, and its core mechanism is to inhibit adrena···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:235
Mitotaneis a drug used to treat inoperable adrenal cortical carcinoma, adrenal hyperplasia, and tumor-induced hypercortisolism, mainly by inhibiting adrenal cortical function.Are t···【more】
Article source:Captain MedicineRelease date:2024-08-20Recommended:203
Mitotaneis a highly potent antineoplastic drug specifically designed to treat inoperable adrenocortical carcinoma and Cushing syndrome.What are the side effects of using Mitotane?T···【more】
Article source:Captain MedicineRelease date:2024-08-19Recommended:253
Anamoreline is the world's first drug for the treatment of cancer cachexia, which was launched in Japan in 2021; By activating ghrelin receptors, it increases appetite and prom···【more】
Article source:Captain MedicineRelease date:2024-08-19Recommended:187
Anamorelin, a drug that specializes in the treatment of cancer cachexia, was launched in Japan in 2021. Anamorelin helps patients increase their appetite and weight by mimicking th···【more】
Article source:Captain MedicineRelease date:2024-08-19Recommended:178
Mitotane, commonly used in the form of tablets, is a highly effective antineoplastic drug for adrenal adenoma without surgical conditions. It is also effective for Cushing syndrome···【more】
Article source:Captain MedicineRelease date:2024-08-19Recommended:225
Mitotane tablets are commonly used in dosage form and are highly effective antineoplastic drugs. We specialize in inoperable adrenocortical tumors and broaden the treatment pathway···【more】
Article source:Captain MedicineRelease date:2024-08-19Recommended:221
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3672024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:612025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:802025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:752025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:932025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: